全文获取类型
收费全文 | 777篇 |
免费 | 59篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 5篇 |
妇产科学 | 30篇 |
基础医学 | 74篇 |
口腔科学 | 5篇 |
临床医学 | 73篇 |
内科学 | 220篇 |
皮肤病学 | 6篇 |
神经病学 | 61篇 |
特种医学 | 23篇 |
外科学 | 190篇 |
综合类 | 8篇 |
预防医学 | 35篇 |
眼科学 | 29篇 |
药学 | 38篇 |
肿瘤学 | 35篇 |
出版年
2023年 | 15篇 |
2022年 | 15篇 |
2021年 | 17篇 |
2020年 | 15篇 |
2019年 | 15篇 |
2018年 | 15篇 |
2017年 | 16篇 |
2016年 | 17篇 |
2015年 | 20篇 |
2014年 | 17篇 |
2013年 | 27篇 |
2012年 | 54篇 |
2011年 | 45篇 |
2010年 | 22篇 |
2009年 | 17篇 |
2008年 | 35篇 |
2007年 | 34篇 |
2006年 | 53篇 |
2005年 | 41篇 |
2004年 | 38篇 |
2003年 | 22篇 |
2002年 | 19篇 |
2001年 | 14篇 |
2000年 | 16篇 |
1999年 | 19篇 |
1998年 | 6篇 |
1997年 | 8篇 |
1996年 | 9篇 |
1995年 | 7篇 |
1994年 | 4篇 |
1992年 | 18篇 |
1991年 | 25篇 |
1990年 | 21篇 |
1989年 | 25篇 |
1988年 | 14篇 |
1987年 | 13篇 |
1986年 | 7篇 |
1985年 | 8篇 |
1984年 | 3篇 |
1983年 | 3篇 |
1982年 | 6篇 |
1981年 | 3篇 |
1980年 | 5篇 |
1979年 | 4篇 |
1978年 | 3篇 |
1977年 | 3篇 |
1970年 | 5篇 |
1969年 | 2篇 |
1968年 | 2篇 |
1967年 | 2篇 |
排序方式: 共有838条查询结果,搜索用时 15 毫秒
21.
22.
Living donor liver transplantation and hepatitis C 总被引:1,自引:0,他引:1
Preliminary results indicate that living donor liver transplantation (LDLT) recipients infected with HCV develop earlier and more severe recurrence than their cadaveric counterparts. The mechanisms underlying this observation are unknown, but could include hepatic regeneration, differences in LDLT recipient demographics, immune homology between donor and recipient, or other factors not previously considered. The optimum clinical approach is to consider LDLT in HCV-infected recipients only as a life-saving procedure and to attempt to eradicate HCV before LT to prevent recurrent infection. 相似文献
23.
Mathias Chamaillard Razvan Iacob Pierre Desreumaux Jean-Frederic Colombel 《Clinical gastroenterology and hepatology》2006,4(2):143-151
Several clinical and biological phenotypes define complex diseases such as inflammatory bowel disease (IBD). There is a critical role of the caspase recruitment domain protein 15/nucleotide-binding oligomerization protein 2-dependent (CARD15-NOD2) sensing of bacterial cell wall components in health and disease. The current etiologic model for IBD emphasizes an interaction between susceptibility and modifier genes along with environmental factors. Together, these lead to disease progression. However, further work should clarify the pathophysiological mechanisms leading to IBD and how innate immune signaling confers susceptibility to intestinal inflammation. This is a prerequisite for rational clinical management of IBD. Genetic, functional, serologic testing and development of therapeutics in IBD are discussed. 相似文献
24.
Ekbom P Damm P Feldt-Rasmussen B Feldt-Rasmussen U Jensen DM Mathiesen ER 《Journal of diabetes and its complications》2008,22(5):297-302
The prevalence of preterm delivery is considerably elevated in women with type 1 diabetes. The aim of the study was to evaluate haemoglobin A(1c) (HbA(1c)) as a predictor of preterm delivery. Two hundred thirteen consecutive pregnant women with type 1 diabetes and normal urinary albumin excretion were included prospectively. HbA(1c) was analyzed at 10, 20 and 28 weeks of gestation. Seventy-one women (33%) delivered pre term and 142 at term. At 10 weeks of gestation, HbA(1c) was 7.3% (S.D. 1.0) vs. 6.9% (S.D. 0.9) (P<.01), at 20 weeks of gestation 6.6% (S.D. 0.7) vs. 6.1% (S.D. 0.7) (P<.001) and at 28 weeks of gestation 6.7% (S.D. 0.8) vs. 6.1% (S.D. 0.7) (P<.001). When comparing HbA(1c) at 10, 20 and 28 weeks of gestation, HbA(1c) at 28 weeks of gestation (P<.001) was the best predictor of preterm delivery. The adjusted odds ratio per 1% increment in HbA(1c) at 28 weeks of gestation was 2.8 (95% CI 1.7-4.4). HbA(1c) at 28 weeks of gestation was a clinical significant predictor of preterm delivery in type 1 diabetes. 相似文献
25.
26.
27.
28.
M. Riisager P.R. Mathiesen J. Vissing N. Preisler M.C. Ørngreen 《Neuromuscular disorders : NMD》2013,23(12):962-968
A recent study has shown that 36 persons who had recovered from juvenile dermatomyositis (JDM) have on average an 18% decrease in maximal oxygen uptake. The objective of this study was to investigate the effect of a 12-week aerobic training program in this group, and assess whether aerobic training can normalize aerobic capacity to the expected level for age and gender.The patients participating in the study, one male and nine females (16–42 years of age), were in remission from JDM, defined as no clinical or biochemical evidence of disease activity and no medical treatment for 1 year. The patients had a median disease duration of 3.4 years (1.4–10.3), a median treatment duration of 2.4 years (0.4–9.3) and a median duration of remission of 7.0 years (1.2–30.0).Patients trained at home on a cycle ergometer for 12 weeks at a heart rate interval corresponding to 65% of their maximal oxygen uptake (VO2max). VO2max and maximal workload (Wmax) were determined before and after the 12-week training period through an incremental cycling test to exhaustion. The patients served as their own controls.Eight patients with JDM in remission completed the 12-week exercise program; one patient completed 9 weeks out of the 12-week program and one dropped out of the study. Training increased VO2max and Wmax by 26% and 30% (P < 0.001). Creatine kinase (CK) levels were normal pre-training and did not change with training, reflecting no muscle damage. We also found that at a given workload, heart rate was lowered significantly after the 12-week training period, indicating an improvement in cardiovascular fitness.This study shows that 12 weeks of moderate-intensity aerobic training is an effective and safe method to increase oxidative capacity and fitness in persons who have recovered from JDM. The results indicate that the low oxidative capacity in JDM patients in remission is reversible and can be improved. Thus, we recommend frequent aerobic training to be incorporated into supervised physiotherapy sessions in the treatment of JDM patients in remission. 相似文献
29.
30.